NIH Scientists See Therapeutic Potential Against Bacteria, Viruses
National Institutes of Health researchers have identified a naturally occurring lipid—a waxy, fatty acid—used by a disease-causing bacterium to impair the host immune response and increase the chance of infection. Inadvertently, they also may have found a potent inflammation therapy against bacterial and viral diseases.
Lipids are known to help Francisella tularensis bacteria, the cause of tularemia, to suppress host inflammation when infecting mouse and human cells. In a new study published in the Journal of Innate Immunity, researchers from NIH’s National Institute of Allergy and Infectious Diseases found a form of the lipid phosphatidylethanoloamine, or PE, present in the bacterium. The composition of PE found in F. tularensis differs from PE found in other bacteria. In cell-culture experiments, the researchers discovered that the natural and a synthetic form of PE reduced inflammation caused by both tularemia bacteria and dengue fever virus.
Tularemia is a life-threatening disease spread to humans via contact with an infected animal or through the bite of a mosquito, tick or deer fly. Although tularemia can be successfully treated with antibiotics, it is difficult to diagnose, mainly because F. tularensis bacteria can suppress the human immune response. Dengue fever, primarily spread by Aedes aegypti mosquitoes, is rarely fatal but usually leads to a high fever, severe headache and pain throughout the body. There is no specific treatment for dengue fever.
After identifying PE as the lipid that impaired the immune response, the scientists began to consider its potential therapeutic value. Because natural F. tularensis is highly infectious and therefore challenging to work with, the group developed synthetic lipids—PE2410 and PEPC2410—that would be much easier to study and produce. They then verified that both synthetic lipids also suppressed the immune response during infection of mouse and human cells in the laboratory.
Because several types of viral infections involve an unconstrained inflammatory response, the group tested natural and their synthetic PE in the laboratory against dengue fever virus-infected human cells. Both versions inhibited the immune response compared to the immune response seen in infected but untreated cells.
The group plans to continue exploring how F. tularensis impairs the immune response. They hope their findings will eventually lead to the development of a potent, broad-spectrum anti-inflammatory therapeutic.
Learn more: Natural Lipid Acts as Potent Anti-Inflammatory
The Latest on: Inflammation therapy
via Google News
The Latest on: Inflammation therapy
- Red Light LED Therapy At Home Kit Reduced Inflammation Solutions Report Launched on September 11, 2018 at 5:00 pm
Bio Hacker Nation launched a new report on RedRush 360, an at-home red light therapy kit designed to reduce inflammation, promote tissue healing and alleviate pain. Bio Hacker Nation, an informative w... […]
- Tezepelumab Granted Breakthrough Therapy Designation By US FDA For The Treatment Of Patients With Severe Asthma Without An Eosinophilic Phenotype on September 6, 2018 at 11:33 pm
A Breakthrough Therapy Designation is designed to expedite the development ... asthma patients independent of baseline blood eosinophil count or other type 2 (T2) inflammatory biomarkers. Currently av... […]
- A common anti-inflammatory therapy may help reduce risk of developing Parkinson's disease on April 23, 2018 at 8:02 am
Immunohistochemistry for alpha-synuclein showing positive staining (brown) of an intraneural Lewy-body in the Substantia nigra in Parkinson's disease. Credit: Wikipedia A recent study from researchers ... […]
- Anti-inflammatory therapy cuts risk of lung cancer on August 28, 2017 at 7:58 am
In most clinical trials for cancer therapy, investigators test treatments in patients with advanced disease. But a recent cardiovascular secondary prevention study has given researchers a unique oppor... […]
- Novel solid forms of the anti-inflammatory drug oxaprozin may lead to a new combined asthma therapy on November 29, 2016 at 4:00 pm
An exploratory study by A*STAR scientists into novel solid forms of the anti-inflammatory drug oxaprozin may lead to improvements for the asthma drug, salbutamol, and help reduce inflammation of the a... […]
- Researchers Shed Light on Anti-Adhesive Molecule in the Vascular Endothelium, Suggest New Direction for Anti-Inflammatory Therapy on February 2, 2016 at 10:20 am
Mass. Eye and Ear researchers describe the role of endomucin, a molecule that – under healthy circumstances – resists the adhesion of white blood cells as they move through the circulatory system. The... […]
- Anti-Inflammatory Therapy in Chronic Disease: Challenges and Opportunities on January 10, 2013 at 4:00 pm
1 Department of Medicine, Department of Anatomy and Cell Biology, and Department of Physiology and Cellular Biophysics, Columbia University, New York, NY 10032, USA. 2 Department of Cellular and Molec... […]
- New therapy protects lungs from runaway inflammation on March 10, 2009 at 5:00 pm
A novel anti-inflammatory therapy designed by Vanderbilt University Medical Center investigators prevents acute lung injury in mice exposed to an inflammation-causing toxin, the researchers report in ... […]
- New Anti-inflammatory Strategy for Cancer Therapy Identified on September 20, 2004 at 12:40 pm
Newswise — A new strategy for cancer therapy, which converts the tumor-promoting effect of the immune system's inflammatory response into a cancer-killing outcome, is suggested in research findings by ... […]
via Bing News